Aloprim and Stevens-Johnson Syndrome (SJS) in California: Get Aggressive Legal Help Now
If SJS/TEN is suspected after exposure to Aloprim (allopurinol sodium), seek emergency care immediately. Allopurinol products carry labeled risks for serious skin reactions, and early discontinuation and inpatient management can be critical (see FDA labeling). California law permits product liability and failure-to-warn claims where warranted (see Carlin v. Superior Court). Contact us to discuss your options: Request a free consultation.
Note: This page provides general information for California matters only and is not legal or medical advice.
What Is Aloprim and How Can It Be Linked to SJS/TEN?
Aloprim is an intravenous formulation of allopurinol used to manage high uric acid levels, including in patients receiving chemotherapy. Stevens-Johnson Syndrome and toxic epidermal necrolysis are rare but severe hypersensitivity reactions. Allopurinol-containing products have documented associations with serious cutaneous adverse reactions, including SJS/TEN, in FDA-approved labeling (Aloprim label).
The Aloprim label warns about severe skin reactions and advises discontinuing allopurinol at the first appearance of a skin rash or other signs of hypersensitivity. It also notes increased risk in certain patients (for example, those with HLA-B*58:01) (FDA labeling).
Recognize Urgent Warning Signs
Seek emergency care immediately if you experience any of the following after Aloprim or other allopurinol exposure:
- Flu-like symptoms, fever, or malaise
- Painful rash, blistering, or skin detachment
- Sores involving the mouth, eyes, or genitals
- Facial swelling or difficulty breathing
Prompt discontinuation of the suspected drug and specialized inpatient care can be lifesaving (FDA labeling). You can report adverse events to the FDA via MedWatch.
Immediate Steps to Protect Your Health and Your Claim
- Get urgent medical treatment and follow specialist guidance.
- Preserve evidence: keep medication packaging, infusion records, hospital wristbands, discharge summaries, and photos of the rash/lesions.
- Document timelines: when Aloprim was administered, first symptoms, ER visits, diagnoses, and follow-ups.
- Limit discussions with insurers or manufacturers until you consult counsel.
- Contact a California product liability lawyer experienced with drug-induced SJS/TEN: Speak with us.
Potential Legal Theories in California
Depending on the facts, claims may include defective design, manufacturing defect, failure to warn (inadequate labeling), breach of warranty, and negligence. In medical settings, claims may also involve professional negligence if standards of care were not met in prescribing, administering, monitoring, or responding to adverse reactions.
California recognizes strict liability for certain product defects, and failure-to-warn theories frequently focus on whether risk information provided to prescribers was adequate and timely under the learned intermediary doctrine (see Carlin v. Superior Court, 13 Cal.4th 1104 (1996); see also Brown v. Superior Court, 44 Cal.3d 1049 (1988)).
Proving Causation in Drug-Related SJS/TEN Cases
Causation is case-specific and typically relies on:
- Medical records and expert review (e.g., dermatology, pharmacology, hematology/oncology)
- Temporal relationship between Aloprim exposure and symptom onset
- Differential diagnosis and exclusion of alternative causes (infections or other drugs)
- Photographs, biopsy results, and hospitalization records
- Batch/lot data, infusion logs, and institutional protocols
- Scientific and regulatory materials (e.g., FDA-approved labeling)
Practical Tips to Strengthen Your Case
- Start a symptom journal with dates, providers, and medications.
- Ask for copies of pathology, dermatology consults, and discharge summaries before leaving the hospital.
- Request pharmacy printouts showing allopurinol/Aloprim lot numbers if available.
- Avoid social media posts about the incident until you speak with counsel.
Compensation You May Seek
Depending on the evidence and applicable law, recoverable damages may include medical expenses (past and future), lost wages and earning capacity, pain and suffering, disfigurement and scarring, vision impairment, assistive devices, home modifications, and, in egregious cases, punitive damages. Families may have wrongful death claims when SJS/TEN is fatal. Outcomes depend on the specific facts and evidence.
California Deadlines and Why Timing Matters
California imposes time limits for filing product liability and medical negligence claims, and additional notice rules can apply in certain contexts. The applicable deadline can vary based on the claim type, the injured person’s age, the discovery of injury, and other factors. For example, medical malpractice claims are subject to specific rules in the California Code of Civil Procedure (California Legislative Information; see also CCP § 340.5). Speak with counsel promptly to avoid missing critical dates.
How a California SJS/TEN Team Builds Your Case
- Rapid evidence preservation and spoliation notices
- Retrieval and review of hospital, infusion, and oncology records; MARs; and pathology reports
- Consultations with dermatology and pharmacovigilance experts
- Evaluation of FDA safety communications and product labeling history for allopurinol products
- Claims strategy tailored to hospital, infusion center, or manufacturer/labeling defendants
- Negotiation with insurers and readiness for trial if necessary
What to Bring to Your Free Consultation
- Hospital discharge summaries and ER records
- Photos of rashes/lesions and any biopsy reports
- Medication list (including chemo agents, antibiotics, anticonvulsants, and allopurinol/Aloprim), with dates and doses if known
- Insurance information and any communications from providers or insurers
- Names of treating physicians and facilities
Frequently Asked Questions
Do I have a claim if I was warned SJS is possible? Potentially. A warning must be adequate, accurate, and communicated through proper channels; case-specific facts matter (see Carlin).
What if I have genetic risk factors? Some populations have higher risk of allopurinol-related SJS/TEN; risk assessment and prescribing decisions can be relevant to liability analyses (FDA labeling).
Can I sue the hospital or infusion center? Possibly, if negligent prescribing, administration, or monitoring contributed to the injury. Liability depends on the medical records and expert review.
Will my case settle? Many cases resolve through settlement, but strong trial preparation often improves outcomes.
Next Steps
If you or a loved one developed SJS/TEN after Aloprim in California, our team can help evaluate your case, secure critical records, and move swiftly to protect your rights. Contact us for a free consultation.